We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Alphabet, Amazon, Apple, Sanofi and Walgreens
Read MoreHide Full Article
For Immediate Release
Chicago, IL – June 20, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alphabet (GOOGL - Free Report) , Amazon (AMZN - Free Report) , Apple (AAPL - Free Report) , Sanofi (SNY - Free Report) and Walgreens (WBA - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Alphabet’s Healthcare Push Gains Steam, Others Brace Up
Alphabet is making every effort to capitalize on the growing dependence of healthcare sector on AI and tools like machine learning (ML), Augmented Reality/ Virtual Reality and Big Data analytics.
The company’s plethora of healthcare initiatives is likely to intensify the competition further in this lucrative space which also includes tech giants like Amazon and Apple.
An Overview of the Google-Sanofi Deal
Alphabet division Google’s latest partnership with Sanofi is reflective of the company’s aggressive stance toward disrupting the healthcare sector and pharmaceutical industry.
Per the partnership terms, Sanofi will leverage Google’s cloud and AI technologies and integrate them into its biological innovations and scientific data which in turn will accelerate the medicine discovery process.
Further, the collaboration will aid in the identification of various type of treatments suitable for patients. Additionally, Google’s AI tools are likely to be utilized by Sanofi in improving marketing and supply efforts and in forecasting sales.
Alphabet’s Pursuit of Dominance
Apart from the latest collaboration on drug discovery, Alphabet’s healthcare division, Verily has teamed up with Novartis, Sanofi, Otsuka and Pfizer to help these pharma companies in reaching the target patients for clinical trials, consequently improving the clinical trial methods.
These alliances are expected to bolster Google’s footprint in specialties like cardiovascular disease, oncology, mental health, dermatology and diabetes.
Notably, Verily’s joint venture with Sanofi, Onduo, targets people with Type 2 diabetes. The collaboration integrates devices, software, medicine and professional care together to provide better treatment and medication.
Moreover, with Walgreens Verily is working on several healthcare projects to make healthcare services affordable for the masses. Verily is working on a medication adherence pilot project which involves deployment of technically advanced devices to ensure the reach of proper medication to patients.
Notably, in early 2019, Verily raised $1 billion in a funding round led by a private equity firm Silver Lake along with Ontario Teachers’ Pension Plan and other global investors. The funding has strengthened Verily’s resources toward strategic investments in healthcare projects, partnerships and acquisitions.
We expect Alphabet’s expanding research and development activities, and collaboration with major healthcare companies to strengthen presence in the healthcare space. Alphabet currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Amazon & Apple: Potent Challengers
Amazon has been eyeing the healthcare market for some time. The e-commerce giant’s buyout of PillPack, an online pharmacy firm, has expanded its footprint in the pharmaceutical industry.
Further, the e-commerce giant has also shown interest in the consumer health diagnostic market. Reportedly, it has plans to develop devices that will enable people to take vital medical tests at home, thereby improving the healthcare delivery time.
Further, this Zacks Rank #3 stock recently started offering the option of paying for medical purchases made on its online retail platform through health savings accounts (HSA) and flexible savings accounts (FSA) debit cards. This will aid Amazon in understanding consumer purchasing pattern, which in turn will help it to enhance services and improve medical supplies business.
Additionally, its service called Amazon Comprehend Medical aids in seamless extraction of medical information related to health condition, medication, dosage and treatment from unstructured data-like test reports, doctor’s notes and audio interviews. The service utilizes robust ML techniques and cloud services to extract data.
Meanwhile, Apple is leaving no stone unturned toward making iOS capable enough for storing and sharing of massive medical data. The updated Health Record section of its Health application enables iPhone users to access their medical records, lab reports and other crucial information from care providers like hospitals and clinics whenever required.
Further, this Zacks Rank #3 stock is looking into a deal with the US Department of Veterans Affairs to simplify hospital visits and improve care and treatment process for the US veterans by providing them access to their health records on iPhones. This will accelerate healthcare delivery times for veterans.
To Conclude
Healthcare’s lucrative growth prospects will continue to allure tech giants. However, initiatives from Alphabet, Amazon and Apple positions them well to capitalize on these prospects.
This Could Be the Fastest Way to Grow Wealth in 2019
Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.
These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Alphabet, Amazon, Apple, Sanofi and Walgreens
For Immediate Release
Chicago, IL – June 20, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alphabet (GOOGL - Free Report) , Amazon (AMZN - Free Report) , Apple (AAPL - Free Report) , Sanofi (SNY - Free Report) and Walgreens (WBA - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Alphabet’s Healthcare Push Gains Steam, Others Brace Up
Alphabet is making every effort to capitalize on the growing dependence of healthcare sector on AI and tools like machine learning (ML), Augmented Reality/ Virtual Reality and Big Data analytics.
The company’s plethora of healthcare initiatives is likely to intensify the competition further in this lucrative space which also includes tech giants like Amazon and Apple.
An Overview of the Google-Sanofi Deal
Alphabet division Google’s latest partnership with Sanofi is reflective of the company’s aggressive stance toward disrupting the healthcare sector and pharmaceutical industry.
Per the partnership terms, Sanofi will leverage Google’s cloud and AI technologies and integrate them into its biological innovations and scientific data which in turn will accelerate the medicine discovery process.
Further, the collaboration will aid in the identification of various type of treatments suitable for patients. Additionally, Google’s AI tools are likely to be utilized by Sanofi in improving marketing and supply efforts and in forecasting sales.
Alphabet’s Pursuit of Dominance
Apart from the latest collaboration on drug discovery, Alphabet’s healthcare division, Verily has teamed up with Novartis, Sanofi, Otsuka and Pfizer to help these pharma companies in reaching the target patients for clinical trials, consequently improving the clinical trial methods.
These alliances are expected to bolster Google’s footprint in specialties like cardiovascular disease, oncology, mental health, dermatology and diabetes.
Notably, Verily’s joint venture with Sanofi, Onduo, targets people with Type 2 diabetes. The collaboration integrates devices, software, medicine and professional care together to provide better treatment and medication.
Moreover, with Walgreens Verily is working on several healthcare projects to make healthcare services affordable for the masses. Verily is working on a medication adherence pilot project which involves deployment of technically advanced devices to ensure the reach of proper medication to patients.
Notably, in early 2019, Verily raised $1 billion in a funding round led by a private equity firm Silver Lake along with Ontario Teachers’ Pension Plan and other global investors. The funding has strengthened Verily’s resources toward strategic investments in healthcare projects, partnerships and acquisitions.
We expect Alphabet’s expanding research and development activities, and collaboration with major healthcare companies to strengthen presence in the healthcare space. Alphabet currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Amazon & Apple: Potent Challengers
Amazon has been eyeing the healthcare market for some time. The e-commerce giant’s buyout of PillPack, an online pharmacy firm, has expanded its footprint in the pharmaceutical industry.
Further, the e-commerce giant has also shown interest in the consumer health diagnostic market. Reportedly, it has plans to develop devices that will enable people to take vital medical tests at home, thereby improving the healthcare delivery time.
Further, this Zacks Rank #3 stock recently started offering the option of paying for medical purchases made on its online retail platform through health savings accounts (HSA) and flexible savings accounts (FSA) debit cards. This will aid Amazon in understanding consumer purchasing pattern, which in turn will help it to enhance services and improve medical supplies business.
Additionally, its service called Amazon Comprehend Medical aids in seamless extraction of medical information related to health condition, medication, dosage and treatment from unstructured data-like test reports, doctor’s notes and audio interviews. The service utilizes robust ML techniques and cloud services to extract data.
Meanwhile, Apple is leaving no stone unturned toward making iOS capable enough for storing and sharing of massive medical data. The updated Health Record section of its Health application enables iPhone users to access their medical records, lab reports and other crucial information from care providers like hospitals and clinics whenever required.
Further, this Zacks Rank #3 stock is looking into a deal with the US Department of Veterans Affairs to simplify hospital visits and improve care and treatment process for the US veterans by providing them access to their health records on iPhones. This will accelerate healthcare delivery times for veterans.
To Conclude
Healthcare’s lucrative growth prospects will continue to allure tech giants. However, initiatives from Alphabet, Amazon and Apple positions them well to capitalize on these prospects.
This Could Be the Fastest Way to Grow Wealth in 2019
Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.
These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.
Click here to see these breakthrough stocks now >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.